JADPRO Live 2017 Educational Activities

These educational activities are based on presentations from JADPRO Live at APSHO 2017. Access the full-length video presentation, the slide deck, transcript, and the entire lecture as a podcast. Click on any of the video presentations below to get started!

All  |  AML  |  AML  |  BRCA  |  Immunotherapy  |  Immunotherapy  |  Immunotherapy  |  Immunotherapy  |  PARP  |  CML  |  MDS  |  MPN  |  Colon Cancer  |  Colorectal Cancer  |  Lynch Syndrome  |  mCRC  |  MSI-H  |  Rectal Cancer  |  CAR T-Cell Therapy  |  irAEs  |  irAEs  |  Side Effect Management  |  ALK Positive NSCLC  |  EGFR Resistance  |  Lymphomas and Leukemias  |  Bladder Cancer  |  Urothelial Carcinoma  |  GIST  |  Leiomyosarcoma  |  Soft Tissue Sarcomas  |  Surgery  |  Drug Development  |  MRD  |  Multiple Myeloma  |  Oral Therapies  |  Risk Stratification  |  Adjuvant Treatment  |  Breast Cancer  |  Diarrhea  |  HER2 Positive Breast Cancer
New Drug Updates in Hematologic Malignancies

This activity is supported by independent educational grants from Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, Puma Biotechnology, Takeda Oncology.

New Drug Updates in Hematologic Malignancies: CAR T Cells, Targeted Therapeutics, and Other Agents

Get an update on the fast-changing world of therapies for hematologic malignancies. With the constantly growing list of new drugs and indications, as well as the introduction of cutting-edge CAR T-cell therapy for the treatment of hematologic malignancies, it’s important that advanced practitioners stay up to date on the latest advances to be able to adequately diagnose, treat, and help patients navigate potential side effects.

Posted: January 22, 2018 / Expires: January 22, 2019

This certified activity has expired but you may watch the video without claiming credit.

Watch Video Without Claiming Credit


Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.